UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Wirz, E G; Jaeger, V K; Allanore, Y; Riemekasten, G; Hachulla, E; Distler, O; Airò, P; Carreira, P E; Tikly, M; Vettori, S; Balbir Gurman, A; Damjanov, N; Müller-Ladner, U; Distler, J; Li, M; Häusermann, P; Walker, U A (2016). Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Annals of the Rheumatic Diseases, 75(7):1285-1292.

Foocharoen, C; Distler, O; Becker, M; Müller-Ladner, U; von Mühlen, C; Leuchten, N; Walker, U A (2012). Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database. Scandinavian Journal of Rheumatology, 41(3):243-246.

Beyer, C; Distler, J H W; Allanore, Y; Aringer, M; Avouac, J; Czirják, L; Cutolo, M; Damjanov, N; Del Galdo, F; Fligelstone, K; Guiducci, S; Kowal-Bielecka, O; van Laar, J M; Martucci-Cerinic, M; Müller-Ladner, U; Riemekasten, G; Tarner, I H; Tyndall, A; Kennedy, A T; Valentini, G; Vettori, S; Walker, U A; Denton, C; Distler, O (2011). EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research. Annals of the Rheumatic Diseases, 70(7):1178-1182.

Avouac, J; Fransen, J; Walker, U A; Riccieri, V; Smith, V; Muller, C; Miniati, I; Tarner, I H; Randone, S B; Cutolo, M; Allanore, Y; Distler, O; Valentini, G; Czirjak, L; Müller-Ladner, U; Furst, D E; Tyndall, A; Matucci-Cerinic, M (2011). Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals of the Rheumatic Diseases, 70(3):476-481.

Finckh, A; Ciurea, A; Brulhart, L; Möller, B; Walker, U A; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C (2010). Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent? Annals of the Rheumatic Diseases, 69(2):387-393.

Koligi, K; Mertz, D; Benz, D; Vogt, T; Bloemberg, G V; Winter, L; Tyndall, A; Battegay, M; Walker, U A (2010). Oligoarthritis durch Tropheryma whipplei „Of bugs and joints“. Der Internist, 52(7):884-888.

Allanore, Y; Meune, C; Vonk, M C; et al; Distler, O; Walker, U A (2010). Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Annals of the Rheumatic Diseases, 69(1):218-221.

Dudler, J; Finckh, A; Kyburz, D; Langenegger, T; Möller, B; Schmiedel, U; Walker, U A (2010). Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis. Swiss Medical Weekly, (140):w13073.

Aschwanden, M; Kesten, F; Stern, M; Thalhammer, C; Walker, U A; Tyndall, A; Jaeger, K A; Hess, C; Daikeler, T (2010). Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Annals of the Rheumatic Diseases, 69(7):1356-1359.

Distler, J H W; Allanore, Y; Avouac, J; Giacomelli, R; Guiducci, S; Moritz, F; Akhmetshina, A; Walker, U A; Gabrielli, A; Müller-Ladner, U; Tyndall, A; Matucci-Cerinic, M; Distler, O (2009). EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Annals of the Rheumatic Diseases, 68(2):163-168.

This list was generated on Mon Jul 24 01:58:44 2017 CEST.